Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Evolutionary Relationships through Genome Comparisons02:54

Evolutionary Relationships through Genome Comparisons

5.7K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Gene Evolution - Fast or Slow?02:05

Gene Evolution - Fast or Slow?

7.0K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
7.0K
Genetic Variation01:25

Genetic Variation

250
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
250
Classification of Systems-II01:31

Classification of Systems-II

132
Continuous-time systems have continuous input and output signals, with time measured continuously. These systems are generally defined by differential or algebraic equations. For instance, in an RC circuit, the relationship between input and output voltage is expressed through a differential equation derived from Ohm's law and the capacitor relation,
132
Classification of Leukocytes01:30

Classification of Leukocytes

1.4K
Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine·2026
Same author

Generating crossmodal gene expression from cancer histopathology improves multimodal AI predictions.

Nature communications·2025
Same author

PEGASUS: Unlocking Polarity in Cell-Permeable Cyclic Peptides Using AI Models Built on Massively Parallel Biological Assays.

Journal of medicinal chemistry·2025
Same author

Probability Distribution for Rare Neutral Mutations in Cancers and Application to Dynamic Precision Medicine of Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Digital twins in oncology: where we are and where we hope to go.

BMJ oncology·2025
Same author

A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer.

medRxiv : the preprint server for health sciences·2025
Same journal

Development and Validation of Salivary Exosomal Tri-RNA Liquid Biopsy in Esophageal Carcinoma: A Multicenter Study.

JCO precision oncology·2026
Same journal

Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.

JCO precision oncology·2026
Same journal

Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer Analysis.

JCO precision oncology·2026
Same journal

Sustained Response to Trametinib in Central Giant Cell Granuloma With <i>KRAS</i> Gain-of-Function Mutation: A Case Report.

JCO precision oncology·2026
Same journal

DNA Damage Response Alterations and Immune Checkpoint Blockade Outcomes Across Multiple Cancers.

JCO precision oncology·2026
Same journal

Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study.

JCO precision oncology·2026
See all related articles

Related Experiment Video

Updated: May 22, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine.

Matthew McCoy1, Chen-Hsiang Yeang2, Shaymaa Bahnassy3

  • 1Department of Oncology, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC.

JCO Precision Oncology
|March 13, 2025
PubMed
Summary
This summary is machine-generated.

Dynamic precision medicine (DPM) offers significant survival benefits, with the first two treatment adaptations providing most of the clinical advantage. This approach identifies patients likely to benefit when DPM recommendations diverge early from current precision medicine (CPM).

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

Related Experiment Videos

Last Updated: May 22, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

Area of Science:

  • Oncology
  • Computational Biology
  • Translational Medicine

Background:

  • Current precision medicine (CPM) faces challenges with treatment resistance due to evolving tumor heterogeneity.
  • Dynamic precision medicine (DPM), an evolutionary guided precision medicine (EGPM) approach, addresses this by tracking genetic diversity and adapting treatments.
  • DPM aims to proactively manage resistance and improve long-term survival through frequent adaptations and combination therapies.

Purpose of the Study:

  • To evaluate the clinical utility of a shortened DPM treatment window, specifically two 6-week adaptations.
  • To determine if limited DPM interventions can yield substantial benefits comparable to more extensive treatment sequences.
  • To assess the cost-effectiveness and feasibility of frequent monitoring in DPM.

Main Methods:

  • Simulated nearly 3 million virtual patients with diverse genetic profiles and treatment responses.
  • Compared treatment outcomes for standard CPM, full DPM (40 moves), and a limited DPM protocol (2 moves).
  • Analyzed DPM input parameters including initial subclone composition, drug sensitivities, and kinetic properties.

Main Results:

  • The initial two DPM adaptations provided comparable average survival benefits to a 40-adaptation sequence across the virtual patient cohort.
  • Patients showed no benefit from DPM if the initial two treatment recommendations matched CPM (65% negative predictive value).
  • A subset of 20% of patients experienced extraordinary benefits from 2-move DPM, similar to 40-move DPM (hazard ratio 0.03).

Conclusions:

  • The first two DPM adaptations capture the majority of the clinical benefit, potentially reducing the need for prolonged, intensive monitoring.
  • An evolutionary classifier can identify patients who will benefit most from DPM, particularly when DPM and CPM recommendations diverge early.
  • These findings support the clinical feasibility of DPM and other EGPM strategies, moving them closer to patient testing.